Browse
Submit Data
Databases
API
Help

Dataset Information

26 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

3-(1H-Imidazol-1-yl)-1-phenyl-propan-1-ol.

ABSTRACT: In the title compound, C(12)H(14)N(2)O, the imidazole ring forms a dihedral angle of 66.73?(5)° with the phenyl ring. In the crystal, mol-ecules are linked via O-H?N and C-H?O hydrogen bonds into sheets lying parallel to (100). The crystal structure is further consolidated by C-H?? inter-actions.

SUBMITTER: Fun HK

PROVIDER: S-EPMC3295423 | biostudies-literature | 2012 Mar

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Publications

3-(1H-Imidazol-1-yl)-1-phenyl-propan-1-ol.

Fun Hoong-Kun HK Quah Ching Kheng CK Attia Mohamed I MI Abdel-Aziz Hatem A HA Al-Rashood Khalid A KA

Acta crystallographica. Section E, Structure reports online 20120210 Pt 3

In the title compound, C(12)H(14)N(2)O, the imidazole ring forms a dihedral angle of 66.73 (5)° with the phenyl ring. In the crystal, mol-ecules are linked via O-H⋯N and C-H⋯O hydrogen bonds into sheets lying parallel to (100). The crystal structure is further consolidated by C-H⋯π inter-actions. ...[more]

PMID: 22412534

Similar Datasets

2-(4,5-Diphenyl-2-p-tolyl-1H-imidazol-1-yl)-3-phenyl-propan-1-ol.

Project description:In the title compound, C(31)H(28)N(2)O, the dihedral angles formed by the imidazole ring with the three aryl substituents are 18.52 (8) and 85.56 (7) and 85.57 (7)°, respectively. In the crystal, mol-ecules are linked by O-H⋯N and C-H⋯O hydrogen bonds into chains parallel to the a axis.

| S-EPMC3274963 | biostudies-literature

2-[2-(2-Nitro-phen-yl)-4,5-diphenyl-1H-imidazol-1-yl]-3-phenyl-propan-1-ol.

Project description:In the title compound, C30H25N3O3, the central imidazole ring forms dihedral angles of 77.34?(6), 12.56?(6) and 87.04?(6)°, respectively, with the o-nitro-benzene ring and the phenyl substituents in the 5- and 4-positions. The mol-ecular conformation is stabilized by weak intra-molecular C-H?? inter-actions. In the crystal, mol-ecules are linked by O-H?N hydrogen bonds, forming chains running parallel to the b-axis direction.

| S-EPMC4011293 | biostudies-literature

2-[2-(5-Bromo-thio-phen-2-yl)-4,5-diphenyl-1H-imidazol-1-yl]-3-phenyl-propan-1-ol.

Project description:In the title compound, C28H23BrN2OS, the dihedral angles formed by the imidazole ring with the 5-bromo-thio-phenyl and phenyl rings are 76.90?(8), 34.02?(10) and 80.93?(11)°, respectively. The chiral centre maintains the S configuration of the l-phenyl-alaninol starting material. In the crystal, mol-ecules are linked by O-H?N hydrogen bonds, forming chains running parallel to the a-axis direction.

| S-EPMC3884508 | biostudies-literature

2-[4,5-Diphenyl-2-(pyridin-2-yl)-1H-imidazol-1-yl]-3-phenyl-propan-1-ol.

Project description:In the title compound, C(29)H(25)N(3)O, the central imidazole ring forms dihedral angles of 64.7?(3), 33.5?(3) and 81.2?(2)° with the pyridyl and two phenyl substituents, respectively. An intra-molecular C-H?N hydrogen bond is observed. In the crystal, O-H?N and C-H?O hydrogen bonds link the mol-ecules into chains parallel to the a axis.

| S-EPMC3379267 | biostudies-other

2-(1H-Benzotriazol-1-yl)-3-(2,6-dichloro-phen-yl)-1-phenyl-propan-1-ol.

Project description:The asymmetric unit of the title compound, C(21)H(17)Cl(2)N(3)O, contains two crystallographically independent mol-ecules with similar conformations. The benzotriazole ring is oriented at dihedral angles of 30.61 (5) and 43.36 (5)°, respectively, to the phenyl and dichloro-phenyl rings in one mol-ecule, and 32.25 (5) and 41.04 (5)° in the other. The dihedral angles between the phenyl and dichloro-phenyl rings are 66.38 (7) and 66.14 (6)° in the two mol-ecules. An intra-molecular O-H⋯N hydrogen bond links the benzotriazole ring and phenyl-propanol unit in each mol-ecule. In the crystal, weak inter-molecular C-H⋯N hydrogen bonds link the mol-ecules into chains along the a axis. π-π stacking between the dichloro-phenyl rings [centroid-centroid distances = 3.809 (1) and 3.735 (1) Å] may further stabilize the crystal structure.

| S-EPMC3200780 | biostudies-literature

Crystal structure of 1-[2-(2,6-di-chloro-phen-yl)-4,5-diphenyl-1H-imidazol-1-yl]propan-2-ol.

Project description:The central imidazole ring of the title compound, C24H20Cl2N2O, is twisted with respect to with the planes of the 2,6-di-chloro-benzene and two phenyl rings, making dihedral angles of 74.06?(18), 28.52?(17) and 67.65?(18)°, respectively. The phenyl ring not adjacent to the N-bonded 2-hy-droxy-propyl group shows the greatest twist, presumably to minimize steric inter-actions. In the crystal, mol-ecules are linked by O-H?N and C-H?O hydrogen-bond contacts into chains along the a-axis direction. The series of parallel chains form a two-dimensional sheet approximately parallel to the bc diagonal. In addition, C-H?? inter-actions are observed between the sheets. The atoms of the 2-hy-droxy-propyl group and the N atom of the 1H-imidazole ring to which it is bonded are disordered over two sets of sites, with an occupancy ratio of 0.722?(5):0.278?(5). The structure was refined as an inversion twin.

| S-EPMC4420112 | biostudies-literature

1-Aryl-3-(1H-imidazol-1-yl)propan-1-ol esters: synthesis, anti-Candida potential and molecular modeling studies.

Project description:BACKGROUND:An increased incidence of fungal infections, both invasive and superficial, has been witnessed over the last two decades. Candida species seem to be the main etiology of nosocomial fungal infections worldwide with Candida albicans, which is commensal in healthy individuals, accounting for the majority of invasive Candida infections with about 30-40% of mortality. RESULTS:New aromatic and heterocyclic esters 5a-k of 1-aryl-3-(1H-imidazol-1-yl)propan-1-ols 4a-d were successfully synthesized and evaluated for their anti-Candida potential. Compound 5a emerged as the most active congener among the newly synthesized compounds 5a-k with MIC value of 0.0833 ?mol/mL as compared with fluconazole (MIC value >1.6325 ?mol/mL). Additionally, molecular modeling studies were conducted on a set of anti-Candida albicans compounds. CONCLUSION:The newly synthesized esters 5a-k showed more potent anti-Candida activities than fluconazole. Compounds 7 and 8 revealed significant anti-Candida albicans activity and were able to effectively satisfy the proposed pharmacophore geometry, using the energy accessible conformers (Econf?<?20 kcal/mol).

| S-EPMC3819650 | biostudies-literature

2-(4-Methyl-phen-yl)-1-(phenyl-sulfon-yl)propan-2-ol.

Project description:The title compound, C(16)H(18)O(3)S, features a U-shape mol-ecular structure with a dihedral angle between the terminal benzene rings of 20.8 (1)°. An intra-molecular O-H⋯O hydrogen bond helps to stabilize the mol-ecular structure. Inter-molecular classical O-H⋯O and weak C-H⋯O hydrogen bonding is present in the crystal structure.

| S-EPMC3247583 | biostudies-literature

1-(2-Methyl-5-nitro-1H-imidazol-1-yl)propan-2-yl acetate.

Project description:In the title compound, C9H13N3O4, an ester of the anti-infection drug secnidazole, the dihedral angle between the nitro-imidazole mean plane (r.m.s. deviation = 0.028 Å) and the pendant acetate group is 43.17 (11)°. In the crystal, inversion dimers linked by pairs of C-H⋯O inter-actions generate R 2 (2)(10) loops and further C-H⋯O hydrogen bonds link the dimers into [100] chains. Weak aromatic π-π stacking inter-actions with a centroid-centroid distance of 3.7623 (11) Å are also observed.

| S-EPMC3998449 | biostudies-literature

RNA sequencing of murine C2C12 cell treated with high-throughput screening hit compound 6,8-dimethyl-3-(4-phenyl-1H-imidazol-5-yl)quinolin-2(1H)-one.

Project description:The hit compound promotes expression and acitivity of alkaline phosphatase in murine cells that are bipotential for myogenic and osteoblastogenic differentiaion. RNA sequecing was performed to assess global transcript expression, with particular attention to genes indicative of osteoblast and bone differentiation.

2020-01-15 | GSE125052 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data